Breaking News, Collaborations & Alliances

Agno Pharma Acquires Lubrizol Particle Sciences

Expands capability and capacity to extend its drug product formulation and clinical manufacturing services.

Agno Pharma, a global pharmaceutical CDMO, acquired Lubrizol Particle Sciences Inc. The acquisition includes the drug product formulation technology behind the Particle Sciences Inc. business as well as the Bethlehem, PA, development, and manufacturing site which employs approximately 65 employees. Particle Sciences specializes in preclinical and clinical stage drug product formulation and offers a comprehensive suite of supporting services, including analytic, bioanalytic, physical character...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters